Kevin Schaab

Dr. Kevin Schaab

Senior Drug Development Consultant

About

Dr. Kevin Schaab has over 25 years of experience in helping develop innovative pharmaceutical therapies, with significant experience in roles spanning pharmaceutical sciences (CMC), non-clinical development, first-in-human to proof-of concept clinical studies, and business development.  

At Quotient Sciences, Kevin is a member of the drug development consultancy team, and is responsible for working with our internal teams to help design and deliver early phase programs along with customer teams.

Kevin holds a PhD in Chemistry from the Florida State University, a Master’s degree in Business Administration from San Diego State University, and a Bachelor of Science degree in Chemistry from the University of Cincinnati. 

Quotient Sciences Logo
Drug Development Consulting, Translational Pharmaceutics, Formulation Development, Drug Product, Careers

The Strategic Role of Drug Development Consultants at Quotient Sciences

Read More

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, commercial manufacturing, Dr. Helen Baker, Dr. Richard Castledine Dr. Helen Baker and Dr. Richard Castledine contribute to Pharmaceutical Technology's 'Poor API Quality Threatens a Healthy Supply' By: Dr. Helen Baker and Dr. Richard Castledine
Read More
News & Announcements, Articles & Publications, Thierry Van Nieuwenhove Thierry Van Nieuwenhove on the Future of CDMO Partnerships By: Thierry Van Nieuwenhove
Read More
News & Announcements, Translational Pharmaceutics®, Articles & Publications BioPharm International interviews Helen Baker about how Quotient Sciences is optimizing drug development
Read More